Medtronic (NYSE:MDT) today announced data from the ALERT trial aimed at addressing health disparities in structural heart care.

Boston Scientific (NYSE:BSX) announced positive data from a randomized clinical trial evaluating its EKOS endovascular system.

Medtronic (NYSE:MDT) announced the launch of the EMBRACE trial of its Symplicity Spyral renal denervation (RDN) system.

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

Boston Scientific (NYSE:BSX) announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.

Distalmotion’s Dexter surgical robotics system challenges the clinical and economic barriers that limit ambulatory surgical ...

An Abbott (NYSE:ABT) official has shared a significant reimbursement win for its Esprit BTK drug-eluting scaffold system.

CMR Surgical announced today that it reached a patient milestone for its surgical robot as it prepares for U.S. market entry.

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

Cognito Therapeutics announced today that it entered into a collaboration with Ochsner Health to advance new approaches to ...

Pixee Medical announced today that it received CE mark approval for Knee+ NexSight, with the first cases already performed in ...

Imperative Care announced today that it enrolled the first patient in the CLEAR-IT study evaluating its Symphony and Prodigy ...